Endoscopic Management of BPH in Immunosuppressed Patients Awaiting Organ Transplantation: Is Aquablation the Right Choice?
Abstract
Aquablation, a robotic water‐jet ablation therapy, has gained popularity as a surgical treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Although it is associated with reduced complication rates and improved preservation of sexual function, its efficacy in complex cases, such as those involving large prostates or patients on immunosuppressive therapy, requires further evaluation. We report the case of a 67‐year‐old male on immunosuppressive therapy who developed bladder neck necrosis following Aquablation for a 90‐g prostate. Postoperative complications included persistent dysuria, incontinence, recurrent urinary tract infections, and pelvic pain. Subsequent management involved completion transurethral resection of the prostate and necrotic tissue, and multidisciplinary collaboration to optimize immunosuppressive therapy. The patient experienced significant symptom resolution following these interventions, highlighting the need for caution when selecting Aquablation for high‐risk patients. This case underscores the importance of thorough preoperative planning and adherence to perioperative guidelines to mitigate risks and improve outcomes in complex surgical cases.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.